Literature DB >> 2079581

Long-term management of respiratory symptoms in advanced cancer.

K Cowcher, G W Hanks.   

Abstract

Respiratory symptoms are a common cause of distress in patients with advanced cancer. Optimal palliative therapy requires careful assessment and the appropriate use of symptomatic measures in conjunction with specific antitumor treatments. The etiology and management of the three major respiratory symptoms, dyspnea, cough and hemoptysis, are described. The indications for antitumor treatments and surgical procedures are briefly outlined, and symptomatic treatments, including drug and nondrug measures, are discussed in detail.

Entities:  

Mesh:

Year:  1990        PMID: 2079581     DOI: 10.1016/0885-3924(90)90048-o

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

1.  High-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airway.

Authors:  Ahmed Elsayem; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2007-07-17       Impact factor: 3.603

Review 2.  WITHDRAWN: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  Claudia Bausewein; Sara Booth; Marjolein Gysels; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

3.  Dyspnea and cancer: support in agonizing conditions.

Authors:  P Drings
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

Review 4.  Dyspnea: assessment and treatment.

Authors:  M Farncombe
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

Review 5.  Exercise therapy in the management of dyspnea in patients with cancer.

Authors:  Graeme J Koelwyn; Lee W Jones; Whitney Hornsby; Neil D Eves
Journal:  Curr Opin Support Palliat Care       Date:  2012-06       Impact factor: 2.302

6.  Clinical application of nebulized opioids for treatment of dyspnoea in patients with malignant disease.

Authors:  M Farncombe; S Chater
Journal:  Support Care Cancer       Date:  1994-05       Impact factor: 3.603

Review 7.  Ethical dilemmas in hospice and palliative care.

Authors:  B M Kinzbrunner
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.